Get started
Author

Rajesh Sivaraman Iyer

Observed name: R. Iyer
ORCID: 0009-0006-0739-6281
Observed ORCID: 0009-0006-0739-6281
OpenAlex ID: A5066388356
Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B
2018 · R. Walsh, R. Hammond, et al. · Journal of Hepatology · 8
SB 9200 an oral selective immunomodulator is safe and efficacious in treatment-naive, non-cirrhotic HBV patients: Results from Cohort 1 of the ACHIEVE trial
2017 · Rmf Yuen, CS Coffin, et al. · 5
LP40 : SB 9200, A novel immunomodulator for patients with viral hepatitis: Phase 1 mad study in patients with hepatitis c virus (HCV) infection
2015 · A. Thompson, S. Roberts, et al. · Journal of Hepatology · 5
Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial
2017 · Stephen Locarnini, Dkh Wong, et al. · 4
Attention-enhanced spatiotemporal deep learning for predictive maintenance in oil and gas assets: towards Maintenance 5.0
2026 · Rajesh Sivaraman Iyer, Sanjaykumar L. Patil, et al. · Scientific Reports · 1
PDF
Next-Generation Predictive Maintenance: Transforming Oil & Gas with Iot-Driven Deep Learning and Industry 5.0 Innovations
2025 · Rajesh Sivaraman Iyer, Sanjaykumar L. Patil, et al. · International Conference on Computational Intelligence and Knowledge Economy (ICCIKE) · 1
Metering Digital Twin: A Game Changer to Monitor MPFM Health and Sustain Accuracy in Well Testing and Custody Meter Transfer
2026 · Hossam El Din Mohamed El Naggar, Subba Ramarao Rachapudi Venkata, et al. · Abu Dhabi International Petroleum Exhibition & Conference (ADIPEC)
Maintenance 5.0: IoT-Enabled Smart Maintenance Systems in Oil & Gas
2025 · Rajesh Sivaraman Iyer, Sanjaykumar L. Patil, et al. · International Conference on Modeling, Simulation & Intelligent Computing (MoSICom)
2403 Comparison of effect of sorafenib (SOR) and CBL0137 (CBL), a novel drug targeting facilitates chromatin transcription (FACT) complex in woodchuck model of hepatitis B-related hepatocellular carcinoma (HCC)
2015 · P. Priyank, A. Purmal, et al. · European Journal of Cancer
2402 Sorafenib (SOR) dose reduction attenuates its immunosuppressive effects and delays hepatocellular cancer (HCC) development in the woodchuck model of hepatitis B related HCC
2015 · R. Iyer, P. Patel, et al. · European Journal of Cancer
Works count: 10
Citation count: 24
H-index: 4
I10-index:
Year
Topic
Type